Icon

Tybost - (150 mg; Tablet, Oral)

Cobicistat Gilead
150 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
None
Indicated to increase systemic exposure of atazanavir or darunavir (once daily dosing regimen) in combination with other antiretroviral agents in the treatment of HIV-1 infection
Yes
***** *** *** ***** ** **** **** ** **** ****** '*** (**** *, ****) *** *** ************ *********. ****** *** ****** ** ** ****** ****, ********** *** ********* **** ***** ***** *** ***** ** ********* *** *** *****. ** ****** ***** ** ****** ***** *** ****** ** ****** '*** ** ** ** *** ******** ******.
Tybost Patent 1 Patent 2
***** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** **** **, **** ******* ******** ***** **** ****
  1. *** **, **** : ***** ******** ****** ***** *** **** ** **** ****** '*** (**** *, ****).
  2. *** **, **** : ****** ***** * **** ******* ***** ** *.*. ******** ***** *** *** ******** ******** ** **** ********.
  3. *** **, **** : ****** ***** * **** ******* ***** ** *.*. ******** ***** ** ******** *** *** **** ******.
  4. *** **, **** : ********** ********* **** ***** *** ****** '*** (**** *, ****) *.*. *** **** ****** ** ****.
  5. *** **, **** : ***** ******** ****** ***** *** **** ** **** ****** ******* ** (****** ** *** **, *****- *** **
  6. *** **, **** : ****** ***** * **** ******* ***** ** *.*. ******** ***** *** *** ******** ******** ** **** ********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.